BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10796128)

  • 21. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.
    Dorenbaum A; Cunningham CK; Gelber RD; Culnane M; Mofenson L; Britto P; Rekacewicz C; Newell ML; Delfraissy JF; Cunningham-Schrader B; Mirochnick M; Sullivan JL;
    JAMA; 2002 Jul; 288(2):189-98. PubMed ID: 12095383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elective cesarean delivery plus short-course lamivudine and zidovudine for the prevention of mother-to-child transmission of human immunodeficiency virus type 1.
    Panburana P; Sirinavin S; Phuapradit W; Vibhagool A; Chantratita W
    Am J Obstet Gynecol; 2004 Mar; 190(3):803-8. PubMed ID: 15042018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe.
    Thistle P; Spitzer RF; Glazier RH; Pilon R; Arbess G; Simor A; Boyle E; Chitsike I; Chipato T; Gottesman M; Silverman M
    Clin Infect Dis; 2007 Jan; 44(1):111-9. PubMed ID: 17143826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An effective and safe protocol involving zidovudine and caesarean section to reduce vertical transmission of HIV-1 infection.
    Grosch-Wörner I; Schäfer A; Obladen M; Maier RF; Seel K; Feiterna-Sperling C; Weigel R
    AIDS; 2000 Dec; 14(18):2903-11. PubMed ID: 11153672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial.
    Taha TE; Kumwenda NI; Gibbons A; Broadhead RL; Fiscus S; Lema V; Liomba G; Nkhoma C; Miotti PG; Hoover DR
    Lancet; 2003 Oct; 362(9391):1171-7. PubMed ID: 14568737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic and other interventions to reduce the risk of mother-to-child transmission of HIV-1 in Europe. The European Collaborative Study.
    Br J Obstet Gynaecol; 1998 Jul; 105(7):704-9. PubMed ID: 9692409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial.
    Petra Study Team
    Lancet; 2002 Apr; 359(9313):1178-86. PubMed ID: 11955535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vertical transmission of HIV infection: risk factors and prevention strategies].
    Grignaffini A; Cavatorta E; Verrotti C; Soncini E; Pelicelli A; Fieni S; Magnani G; Benaglia G
    Acta Biomed Ateneo Parmense; 2000; 71(5):167-78. PubMed ID: 11450119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.
    Stiehm ER; Lambert JS; Mofenson LM; Bethel J; Whitehouse J; Nugent R; Moye J; Glenn Fowler M; Mathieson BJ; Reichelderfer P; Nemo GJ; Korelitz J; Meyer WA; Sapan CV; Jimenez E; Gandia J; Scott G; O'Sullivan MJ; Kovacs A; Stek A; Shearer WT; Hammill H
    J Infect Dis; 1999 Mar; 179(3):567-75. PubMed ID: 9952362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of vertical HIV transmission: additive protective effect of elective Cesarean section and zidovudine prophylaxis. Swiss Neonatal HIV Study Group.
    Kind C; Rudin C; Siegrist CA; Wyler CA; Biedermann K; Lauper U; Irion O; Schüpbach J; Nadal D
    AIDS; 1998 Jan; 12(2):205-10. PubMed ID: 9468370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perinatal Antiretroviral Intensification to Prevent Intrapartum HIV Transmission When Antenatal Antiretroviral Therapy Is Initiated Less Than 8 Weeks Before Delivery.
    Lallemant M; Amzal B; Sripan P; Urien S; Cressey TR; Ngo-Giang-Huong N; Klinbuayaem V; Rawangban B; Sabsanong P; Siriwachirachai T; Jarupanich T; Kanjanavikai P; Wanasiri P; Koetsawang S; Jourdain G; Le Coeur S;
    J Acquir Immune Defic Syndr; 2020 Jul; 84(3):313-322. PubMed ID: 32205720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1.
    Read JS; Newell MK
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005479. PubMed ID: 16235405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of mother-to-infant human immunodeficiency virus 1 transmission before and after the introduction of zidovudine prophylaxis.
    Italian Register for Human Immunodeficiency Virus Infection in Children
    Arch Pediatr Adolesc Med; 2002 Sep; 156(9):915-21. PubMed ID: 12197800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection.
    Wiysonge CS; Shey M; Kongnyuy EJ; Sterne JA; Brocklehurst P
    Cochrane Database Syst Rev; 2011 Jan; (1):CD003648. PubMed ID: 21249656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mother to child transmission of HIV.
    Volmink J
    Clin Evid; 2002 Jun; (7):709-16. PubMed ID: 12230698
    [No Abstract]   [Full Text] [Related]  

  • 36. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies.
    ; Andiman W; Bryson Y; de Martino M; Fowler M; Harris D; Hutto C; Korber B; Kovacs A; Landesman S; Lindsay M; Lapointe N; Mandelbrot L; Newell M-L; Peavy H; Read J; Rudin C; Semprini A; Simonds R; Tuomala R
    N Engl J Med; 1999 Apr; 340(13):977-87. PubMed ID: 10099139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection.
    Bhana N; Ormrod D; Perry CM; Figgitt DP
    Paediatr Drugs; 2002; 4(8):515-53. PubMed ID: 12126455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The reduction of mother-child transmission of HIV infection in developing countries: potential intervention strategies, obstacles to implementation and perspectives. The Reduction of Mother-Child Transmission of HIV Infection in Africa Group].
    Meda N; Msellati P; Welffens-Ekra C; Cartoux M; Leroy V; Van de Perre P; Salamon R
    Sante; 1997; 7(2):115-25. PubMed ID: 9273118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial.
    European Mode of Delivery Collaboration
    Lancet; 1999 Mar; 353(9158):1035-9. PubMed ID: 10199349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.